API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Side effects of Enfuvirtide

Enfuvirtide is an antiretroviral drug used in salvage regimens in (usually) highly drug-experienced individuals that suppresses replication of HIV-1 strains with multidrug resistance to reverse transc

Apr 2,2022  API

Mechanism of action of Tipranavir

Tipranavir (formerly known as PNU-140690) is the first of a new class of nonpeptide protease inhibitors, the dihydropyrone sulfonamides. Tipranavir was developed and is marketed by Boehringer Ingelhei

Apr 2,2022  API

Uses and Side effects of Atazanavir

Atazanavir (ATV) sulfate, (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)- 8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl] methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester

Apr 2,2022  API

Uses and Side effects of Darunavir

Darunavir is a synthetic nonpeptidic analog of amprenavir that functions as a human immunodeficiency virus (HIV) protease inhibitor. HIV protease cleaves gag-pol proteins in HIV-infected cells and thu

Apr 2,2022  API

Side effects of Fosamprenavir

Fosamprenavir is a sulfa-containing calcium phosphate ester prodrug of amprenavir. Like other HIV-1 protease inhibitors, amprenavir binds to the active site of the HIV-1 protease. This prevents the pr

Apr 2,2022  API

Side effects of Lopinavir

Lopinavir (formerly known as ABT-378) is an HIV-1-specific protease inhibitor engineered specifically to address the shortcomings of earlier agents in the protease inhibitor class.

Apr 1,2022  API

Uses and side effects of Nelfinavir

Nelfinavir is used primarily for the treatment of HIV-1 infection, but has also been recently used in patients with malignancy.

Apr 1,2022  API

Side effects of Indinavir

Indinavir is formulated as a sulfate salt and is available from the manufacturer for oral administration in strengths of 100, 200, 333, and 400 mg of indinavir.

Apr 1,2022  API

Mechanism of action of Ritonavir

Ritonavir is a peptidomimetic inhibitor of HIV-1 and HIV-2 proteases. It is marketed by Abbott Laboratories under the brand name Norvir.

Apr 1,2022  API

Uses and toxicity of Saquinavir

Saquinavir, a synthetic peptidomimetic analog that inhibits HIV protease, was developed using computer-led rational design technology and was the first commercially available antiretroviral protease i

Apr 1,2022  API
Prev12345678910...Next>  Go to Page